This trial was a double-blind, randomized, Phase 2 study, performed in patients with type 2 diabetes, received either once-weekly subcutaneous LY3298176 (1 mg, 5 mg, 10 mg, or 15 mg), dulaglutide (1,5 mg), or placebo [19]
But if the provider loses access to their compounding pharmacy due to FDA enforcement, you could be paying for a service that can no longer deliver medication
A smaller subset experiences persistent but manageable diarrhea that doesn't interfere with daily function
Developing oral pet GLP-1 medicines or supplements with increased absorption or bioavailability
HEK-Blue GLP-1 cells express approximately 1,000 GLP-1 receptors per cell, a surface receptor density consistent with physiological levels reported in the literature [1,2]
A two-site rotation between thigh and abdomen, switching left and right, provides eight distinct zones